Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Journal of Psychopharmacology (Oxford, England)|October 8, 1999
Comparative effects of serotonergic agonists with varying efficacy at the 5-HT(1A) receptor on core body temperature: modification by the selective 5-HT(1A) receptor antagonist WAY 100635J F Cryan, P Kelliher, J P Kelly, et al.
Neuroscience|October 4, 2015
Early-life adversity and brain development: Is the microbiome a missing piece of the puzzle?S M O'Mahony, G Clarke, T G Dinan, et al.
Irish Journal of Psychological Medicine|August 18, 2018
Dimensional thinking in psychiatry in the era of the Research Domain Criteria (RDoC)J R Kelly, G Clarke, J F Cryan, et al.
European Journal of Pharmacology|August 26, 1998
Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected?J F Cryan, C McGrath, B E Leonard, et al.
Neuropharmacology|July 10, 2016
Kynurenine pathway metabolism and the microbiota-gut-brain axisP J Kennedy, J F Cryan, T G Dinan, et al.
Neuroscience|October 17, 2012
Lithium augmentation of the effects of desipramine in a mouse model of treatment-resistant depression: a role for hippocampal cell proliferationO F O'Leary, S Zandy, T G Dinan, et al.
The Australian and New Zealand Journal of Psychiatry|February 24, 2001
Pindolol augmentation of antidepressants: a review and rationaleJ S Olver, J F Cryan, G D Burrows, et al.
Neurogastroenterology and Motility|September 26, 2015
Early-life stress-induced visceral hypersensitivity and anxiety behavior is reversed by histone deacetylase inhibitionR D Moloney, R M Stilling, T G Dinan, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 1, 1997
The effects of the 5-HT1A agonist flesinoxan, in three paradigms for assessing antidepressant potential in the ratJ F Cryan, A M Redmond, J P Kelly, et al.
Neuroscience|September 22, 2009
Colorectal distension-induced prefrontal cortex activation in the Wistar-Kyoto rat: implications for irritable bowel syndromeS M Gibney, R-D Gosselin, T G Dinan, et al.
Pageof 8